Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Hear me now and understand me later

<< Previous

Bullboard Posts

Next >>

Comment by Actuarialon May 20, 2021 12:40pm

144 Views

Post# 33240842

RE:RE:RE:Hear me now and understand me later

Nope. I have more than 150K ATE share and keep accumulating. Just want to grab more shares at bargin price.

YukonJezza wrote:

Actuarial wrote: I don't need to understand you - I just need to buy your shares if would like to put a sell order at $4.02. I have cash, you have shares, and you believe the share price will be below $4.00. It is a perfect match. Let's do it!

I am buying shares too. Are you covering a SHORT?